EU Medtechs Keep Open Mind On HTA Options In Wider Market Access Plan
Health technology assessment for medtech products in Europe is a strictly national responsibility, but is there a case for an EU-wide HTA system that could improve medtech market access? MedTech Europe chief executive Serge Bernasconi shares his views with In Vivo.
You may also be interested in...
Navigating the UK medtech innovation landscape is a notoriously complicated exercise, so industry is hoping the recently released Accelerated Access Review will have positive outcomes as 2018 unfolds. Andrew Davies, market access director for the Association of British Healthcare Industries, says a simplified system of market access for medtech would bring benefits across the board.
A short comment period for Germany’s future hospital financing bill will be followed by parliamentary debate before it becomes law.
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.